Consumer News Ftc Report Says Pharmacy Benefit Managers Keep Drug Prices High

Prescription drug middlemen fight FTC oversight at Eighth Circuit

The pharmacy benefit managers claim the government agency violates due process rights by acting as investigator, prosecutor and judge in its own administrative court. Read More

Eighth Circuit Hears Challenge to FTC Action Over Insulin Costs

Judges on a federal appeals court questioned pharmacy benefit managers Wednesday over the merits of their case against the Federal Trade Commission, which seeks to halt the agency’s internal ... Read More

How Trump’s FTC Can Keep Drug Prices Down for Working Americans

Joseph R. Pitts served as a member of the U.S. House from Pennsylvania. He chaired the House Energy & Commerce Committee’s Subcommittee on Health. How do leading retailers like Amazon and Walmart ... Read More

President Trump’s Executive Orders On Prescription Drug Prices: What The Evidence Says

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Read More

Gavin Newsom signs CA bill to lower medication costs, rein in insurance middlemen

California Gov. Gavin Newsom on Saturday signed Senate Bill 41, a bill that would impose regulations on insurance-industry middlemen who are accused of driving up prices for prescription drugs, and ... Read More

Lawmakers in Oklahoma plan to strengthen regulations on pharmacy benefit managers

State and federal Oklahoma lawmakers say they plan to prioritize enforcement actions on pharmacy benefit managers, the managers of prescription drugs. Read More